Institute of New Drug Development, China Medical University, Taichung, Taiwan.
Regenerative Medicine Cluster, Advanced Medical and Dental Institute (AMDI) Universiti Sains Malaysia, Penang, Malaysia.
Sci Rep. 2017 Apr 11;7(1):793. doi: 10.1038/s41598-017-00912-3.
Measuring at ~30 nm, a fully customizable holliday junction DNA nanoconstruct, was designed to simultaneously carry three unmodified SiRNA strands for apoptosis gene knockout in cancer cells without any assistance from commercial transfection kits. In brief, a holliday junction structure was intelligently designed to present one arm with a cell targeting aptamer (AS1411) while the remaining three arms to carry different SiRNA strands by means of DNA/RNA duplex for inducing apoptosis in cancer cells. By carrying the three SiRNA strands (AKT, MDM2 and Survivin) into triple negative breast MDA-MB-231 cancer cells, cell number had reduced by up to ~82% within 24 hours solely from one single administration of 32 picomoles. In the immunoblotting studies, up-elevation of phosphorylated p53 was observed for more than 8 hours while the three genes of interest were suppressed by nearly half by the 4-hour mark upon administration. Furthermore, we were able to demonstrate high cell selectivity of the nanoconstruct and did not exhibit usual morphological stress induced from liposomal-based transfection agents. To the best of the authors' knowledge, this system represents the first of its kind in current literature utilizing a short and highly customizable holliday DNA junction to carry SiRNA for apoptosis studies.
该研究设计了一种完全可定制的约 30nm 的霍利迪连接 DNA 纳米结构,用于在没有任何商业转染试剂盒辅助的情况下,同时携带三条未经修饰的 siRNA 链,以实现癌细胞中的凋亡基因敲除。简而言之,该研究设计了一种霍利迪连接结构,其中一个臂带有细胞靶向适体(AS1411),而其余三个臂通过 DNA/RNA 双链携带不同的 siRNA 链,从而诱导癌细胞凋亡。通过将三条 siRNA 链(AKT、MDM2 和 Survivin)导入三阴性乳腺癌 MDA-MB-231 细胞中,在单次给予 32 皮摩尔的剂量后,细胞数量在 24 小时内减少了约 82%。在免疫印迹研究中,观察到磷酸化 p53 的上调超过 8 小时,而在给予药物后 4 小时,三个感兴趣的基因被抑制了近一半。此外,我们能够证明该纳米结构具有很高的细胞选择性,并且没有表现出基于脂质体的转染剂通常引起的形态学应激。据作者所知,该系统代表了当前文献中利用短而高度可定制的霍利迪 DNA 连接携带 siRNA 进行凋亡研究的首例。